Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Im­muno­log­i­cal Medicines for Hors­es

Immunological veterinary medicinal products, including vaccines, are authorised for horses.

Search results 1 to 25 from a total of 32

Name De­scrip­tion Mar­ket­ing Au­tho­ri­sa­tion Hold­er Li­cense Num­ber Li­cense Date An­i­mal Further Information

Ar­ti-Cell Forte

Al­lo­gene pe­riph­ere mes­enchy­male Stam­mzellen aus dem Blut vom Pferd, chon­dro­genin­duziert

Glob­al Stem cell Tech­nol­o­gy (G.S.T.) NV, Bel­gien

EU/2/18/228 29.03.2019 Pferd

EPAR: Ar­ti-Cell Forte

BioE­quin H

Equines Her­pesvirus (EHV) Typ 1

Biove­ta, a.s., Tschechien

PEI.V.11912.01.1 24.08.2017 Pferd

Equi­lis Pre­quen­za

Pfer­de­in­fluen­za

In­ter­vet In­ter­na­tion­al BV, Nieder­lande

EU/2/05/056/001-004 12.07.2005 Pferd

EPAR: Equi­lis Pre­quen­za

Equi­lis Pre­quen­za Te

Pfer­de­in­fluen­za,
Tetanus

In­ter­vet In­ter­na­tion­al BV, Nieder­lande

EU/2/05/057/001-004 12.07.2005 Pferd

EPAR: Equi­lis Pre­quen­za Te

Equi­lis StrepE

Druse

In­ter­vet In­ter­na­tion­al BV, Nieder­lande

EU/2/04/043/001 11.05.2004 Pferd

EPAR: Equi­lis StrepE

Equi­lis Te

Tetanus

In­ter­vet In­ter­na­tion­al B.V., Nieder­lande

EU/2/05/055/001-002 12.07.2005 Pferd

EPAR: Equi­lis Te

Equi­lis West Nile

West-Nil-Viruserkrankung

In­ter­vet In­ter­na­tion­al BV, Nieder­lande

EU/2/13/151/001-003 06.06.2013 Pferd

EPAR: Equi­lis West Nile

Equi­lis- Tetanus- Serum

Serum gegen Tetanus

In­ter­vet Deutsch­land GmbH

A164/79d 23.12.2005 Pferd, Hund, Schaf

Equip Arter­vac

Equine Ar­teri­tis

Zoetis Deutsch­land GmbH

PEI.V.01240.01.1 23.05.2002 Pferd, Pony

Equip EHV 1,4

Rhinop­neu­moni­tis,
Aborte durch EHV

Zoetis Deutsch­land GmbH

12a/97 18.08.1997 Pferd

Equip F

Pfer­de­in­fluen­za

Zoetis Deutsch­land GmbH

PEI.V.02824.01.1 21.10.2003 Pferd, Pony

Equip FT

Pfer­de­in­fluen­za, Tetanus

Zoetis Deutsch­land GmbH

PEI.V.02825.01.1 21.10.2003 Pferd, Pony

Equip Ro­tavirus

Equines Ro­tavirus

Zoetis Deutsch­land GmbH

PEI.V.11552.01.1 02.02.2012 Pferd

Equip T

Tetanus

Zoetis Deutsch­land GmbH

4a/97 22.02.2000 Pferd

Equip WNV

West-Nil-Viruserkrankung

Zoetis Bel­gium S.A., Bel­gien

EU/2/08/086/004-006 21.11.2008 Pferd

EPAR: Equip WNV (pre­vi­ous­ly Du­vaxyn WNV)

Equiphyt

Tri­chophytie

Vir­bac Tier­arzneimit­tel GmbH

PEI.V.04253.01.1 23.06.2008 Pferd

Eq­ui­Shield EHV

Equines Her­pesvirus (EHV) Typ 1

Dechra Reg­u­la­to­ry B.V., Nieder­lande

PEI.V.11982.01.1 23.01.2019 Pferd

Fohlen­lähme-Mis­chserum

Serum gegen Aufzucht­krankheit­en

WdT - Wirtschafts­genossen­schaft Deutsch­er Tierärzte eG

A269/79 27.12.2005 Pferd

Hip­po Tri­chon

Tri­chophytie

Ecuphar NV, Bel­gien

PEI.V.02610.01.1 06.04.2004 Pferd

HorStem

Mes­enchy­male Stam­mzellen vom Pferd, ex­trahiert aus Nabelschnur des Pferds

EquiCord-YMAS S.L., Spanien

EU/2/18/226 19.06.2019 Pferd

EPAR:

In­sol Der­mato­phy­ton

Tri­chophytie,
Mikrosporie

Boehringer In­gel­heim Vetmed­i­ca GmbH

118a/96 27.02.1999 Hund, Katze, Pferd

No­bi­vac T

Toll­wut

In­ter­vet Deutsch­land GmbH

348a/94 11.08.1997 Frettchen, Hund, Katze, Pferd, Rind, Schaf

Pre­vac­ci­nol

Rhinop­neu­moni­tis

In­ter­vet Deutsch­land GmbH

A196/79 22.03.2004 Pferd, Pony

Pro­teq West Nile

West-Nil-Viruserkrankung

Boehringer In­gel­heim Vetmed­i­ca GmbH

EU/2/11/129/001-004 05.08.2011 Pferd

EPAR: Pro­teq West Nile

Pro­te­qFlu

Pfer­de­in­fluen­za

Boehringer In­gel­heim Vetmed­i­ca GmbH

EU/2/03/037/005 10.03.2003 Pferd

EPAR: Pro­te­qFlu

Disclaimer

The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 514 in BAnz AT 01.03.2024 B8.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

Updated: 04.03.2024